Learn more

NIPPON HYPOX LAB INC

Overview
  • Total Patents
    113
  • GoodIP Patent Rank
    217,302
About

NIPPON HYPOX LAB INC has a total of 113 patent applications. Its first patent ever was published in 1985. It filed its patents most often in Japan, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and basic materials chemistry are KRKA TOVARNA ZDRAVIL D D NOVO, KANOLDT ARZNEIMITTEL GMBH and BRISTOL MYERS SQUIBB HOLDINGS IRELAND.

Patent filings per year

Chart showing NIPPON HYPOX LAB INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Matsumoto Hitoshi 56
#2 Satoh Toshio 53
#3 Niiro Yasunori 31
#4 Kakegawa Hisao 30
#5 Miki Tokutaro 27
#6 Sato Toshio 24
#7 Nishikawa Yoji 15
#8 Kakegawa Toshio 14
#9 Sugiyama Satoru 12
#10 Niino Yasunori 11

Latest patents

Publication Filing date Title
WO2015093579A1 Preventative and therapeutic agent for diabetic nephropathy
JP2009256226A Hepatic fibrosis inhibitor
JP2009102262A Curative drug for neurodegenerative disease
JP2008266172A Method for producing 3-o-alkyl-5,6-o-(1-methylethylidene)-l-ascorbic acid and method for producing 5,6-o-(1-methylethylidene)-l-ascorbic acid
JP2004352661A Agent for treating intractable inflammatory disease
JP2004352660A Hair-growing cosmetic
JP2004217548A Cosmetic containing ascorbic acid derivative
JP2004075579A Antipruritic agent for external use
JP2004075578A Prophylactic and therapeutic medicament for oculopathy
JP2003113082A Composition for oral hygiene
JP2003026592A Anti-androgenic agent comprising fermented licorice extract
JP2002284665A Cosmetics
JP2002284666A Cosmetics
JP2002284626A External skin preparation
JP2002284625A Cosmetics
JP2002284623A Cosmetics
JP2002241366A Hydroquinone derivative and composition for treatment of arteriosclerosis
US6447817B1 Anti-inflammatory analgesic
WO9922709A1 Cosmetics and process for the preparation of extract of the nest of $i(oceanodroma sp.)
WO9605202A1 Imidazoquinoline derivative